Introduction
Although effective in preventing death due to end-stage renal disease,' regular haemodialysis is expensive. The cost of treat-UK Transplant, Bristol N H SELWOOD, BSC, PHD, principal scientific officer, organ matching service ment in the United Kingdom was recently estimated to be £10 000 per year per patient for hospital haemodialysis and £6000 per year for home haemodialysis.' Most doctors therefore accept that they should make all possible economies in materials and staff. Economic measures may reduce safety and additional risks must be acceptable both medically and legally.
Disposable dialysers are gradually displacing non-disposable ones in the UK because they have several advantages over the non-disposable (Kiil) type. They are easier to store and use and patients can use them at home without the structural alterations that may be necessary to accommodate a Kiil dialyser.
Disposable dialysers do not, however, provide dialysis as cheaply as non-disposable parallel-flow dialysers. A modern Meltec Multipoint dialyser with trolley costs £560, and yearly costs for membranes, blood ports, and regasketing are about £100. The dialyser boards and trolley will probably serve an individual patient for at least two and possibly three or four years. The average annual cost for this equipment is thus £240 to £380. Disposable dialysers cost from £10 to £25 each, depending on the type and on bulk purchasing agreements. They therefore cost six to 14 times as much per year as nondisposable equipment. The cost can be reduced if the haemodialysers are not discarded after use but rinsed and resterilised for reuse. If they are reused three times disposable dialysers are only about twice as expensive as non-disposable equipment, and after seven reuses they are beginning to be cheaper. (These cost comparisons are based on material costs alone. The building, testing, and sterilising of the Kiil type of dialyser takes about one man-hour and unless the patient carries this out himself a skilled kidney builder must be paid to do it.)
We surveyed the practice of reuse in renal units in the United Kingdom and investigated its mortality and morbidity. We also inquired about the views held in renal units about the necessity and ethics of reusing "disposable" dialysers.
Methods
The registration committee of the European Dialysis and Transplant Association collects yearly returns from all UK centres as part of a survey covering 27 countries.' Information is returned on individual patient questionnaires, which record (among other data) the type of dialyser used most often for the patient and the average number of reuses of the dialyser. Returns for 1976 were received from 54 out of 56 UK units.
Mortality in patients who reused disposable dialysers was compared with mortality in patients who did not reuse. To remove bias due to disparities in the age distribution in the two groups we studied only patients aged 15-34 years.
Morbidity was assessed by a special questionnaire circulated among UK units which included questions on pyrexial reactions, bacteraemias, other types of cross infection, and incidents associated with sterilising agents. 4 We also asked about any other complications attributed to reuse, including membrane rupture.
Opinions about reusing dialysers were sought by presenting a spectrum of views from which respondents could select those with which they agreed. Replies to this special questionnaire were received from 49 out of 56 units. Thirty-three units had some experience of reuse of disposable dialysers; 16 did not reuse.
Results
Information on the types of dialysers and on the practice of reuse in the United Kingdom is given in tables I and II. Comparison with previous years' analyses indicates that the proportion of patients using disposable dialysers is increasing while the proportion using nondisposable dialysers is decreasing. In this trend the United Kingdom has followed European practice, but over 60 % of UK patients still used non-disposable parallel flow dialysers in 1976 compared with 11", of European patients. The proportion of patients undergoing hospital dialysis was smaller than that of home dialysis patients, and this remained true when the groups of dialysers were considered separately. Those There is understandable commercial resistance to the reuse of disposable dialysers. Because manufacturers do not authorise the practice officially some centres that have wanted to reuse and save money with which to treat other patients have been stopped from doing so by their hospital administration because of fears of litigation. This embargo might also gain support from bacteriological purists. Were it to become nationwide, however, it would result in extra expenditure of almost Clm a year solely to eliminate the reuse of disposable dialysers on the scale practised in 1976. This money could fund 150 patient-years' home dialysis at the costs quoted in our introduction.
Financial constraint has made it necessary for many physicians to decide to reuse "disposable" dialysers. Ethical responsibility for this decision must remain with the clinician. Nevertheless, the results of our survey should show that there is no need to fear any inquiry by the courts. Summary and conclusions The labour records of 1000 consecutive deliveries were studied to compare the incidence of postpartum haemorrhage after induced labour with that after spontaneous labour. The discovery of an increased incidence of postpartum haemorrhage in the induced group prompted further analysis of the incidence of haemorrhage among 3674 normal deliveries. This analysis confirmed that the incidence of postpartum haemorrhage was increased after induction of labour; among primiparous patients the increased incidence after induced labours was nearly twice that after spontaneous labours, even when only normal deliveries were considered.
These findings indicate that postpartum haemorrhage is another complication of induction that needs to be taken into account when induction is being considered. Introduction A review of the maternity statistics of St Mary's Hospital, Portsmouth, showed an increasing incidence of postpartum haemorrhage. In 1967-9 there were 14 617 deliveries, with a surgical induction of labour rate of 39100 and a postpartum haemorrhage rate of 5 1°. During 1970-2 there were 15 243 deliveries, a 36-50o induction rate, and a haemorrhage rate of 5-6°0. In 1973-5, however, with 14 222 deliveries and an induction rate of 421"%, the incidence of postpartum haemorrhage had increased to 860'. We therefore examined the causes of the increased incidence of haemorrhage. There had been no change in the management of the third stage of labour during 1973-5, but there had been a change in the management of the first stage of labour: from 1973 intravenous oxytocin infusions have been started synchronously with surgical induction of labour, and the concept of "active management" has been accepted.
Patients and methods
The study was undertaken in two parts. Initially the labour records of 1000 consecutive deliveries from January 1974 to April 1975, all under the care of one consultant, were studied. The duration of labour and whether it was spontaneous or induced; parity; recorded blood loss for the delivery; the occurrence of postpartum haemorrhage; abnormal deliveries (forceps, Ventouse, breech, twins); and caesarean sections were recorded. (The blood loss at caesarean section was not included in the mean blood loss survey.)
In the second survey the delivery statistics for 1974, which were already stored in the computer, were analysed. Of the 4839 deliveries, 3674 were normal. Altogether 1897 of these labours were spontaneous and 1777 were induced. As in the original survey, we could not differentiate between spontaneous labour, non-accelerated labour, and accelerated labour.
Induction-In this hospital labour is induced by forewater amniotomy and simultaneous oxytocin titration intravenous infusion. The infusion is started at 1 mU/min and doubled every quarter of an hour to 8 or 16 mU/min, where it is maintained if good contractions are being produced and progressive cervical dilatation is being achieved.
Syntometrine (ergometrine 0 5 mg and oxytocin 5 units) one ampoule intramuscularly is routinely given with the delivery of the anterior shoulder of the baby. The third stage of labour is managed by continuous cord traction after the uterus has retracted. The oxytocin intravenous infusion is continued for at least 30 minutes after the third stage has been completed.
Results and comment Table I shows the results of the initial survey. There was a small but not statistically significant difference in the incidence ofpostpartum haemorrhage between the two groups. To obtain a more homogeneous
